Journal
ADVANCED SCIENCE
Volume 8, Issue 3, Pages -Publisher
WILEY
DOI: 10.1002/advs.202003097
Keywords
deep learning; multitask residual dense networks; optical‐ resolution photoacoustic microscopy; ultralow laser dosage
Categories
Funding
- National Natural Science Foundation of China (NSFC) [91739117, 81873919, 81371662, 81927807]
- Shenzhen Science and Technology Innovation Grant [JCYJ20170413153129570]
- Chinese Academy of Sciences Grant [YJKYYQ20190078, 2019352, GJJSTD20180002]
- Key Special Project of Ministry of Science and Technology China [2020YFA0908802]
Ask authors/readers for more resources
Optical-resolution photoacoustic microscopy (OR-PAM) is an excellent modality for in vivo biomedical imaging, but faces challenges such as high excitation laser dosage, limited imaging speed, and imperfect image quality. A deep learning method called multitask residual dense network was proposed to overcome these challenges, achieving high-quality images under ultralow laser dosage and potentially meeting clinical requirements with a high-quality, high-speed OR-PAM system.
Optical-resolution photoacoustic microscopy (OR-PAM) is an excellent modality for in vivo biomedical imaging as it noninvasively provides high-resolution morphologic and functional information without the need for exogenous contrast agents. However, the high excitation laser dosage, limited imaging speed, and imperfect image quality still hinder the use of OR-PAM in clinical applications. The laser dosage, imaging speed, and image quality are mutually restrained by each other, and thus far, no methods have been proposed to resolve this challenge. Here, a deep learning method called the multitask residual dense network is proposed to overcome this challenge. This method utilizes an innovative strategy of integrating multisupervised learning, dual-channel sample collection, and a reasonable weight distribution. The proposed deep learning method is combined with an application-targeted modified OR-PAM system. Superior images under ultralow laser dosage (32-fold reduced dosage) are obtained for the first time in this study. Using this new technique, a high-quality, high-speed OR-PAM system that meets clinical requirements is now conceivable.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available